U.S. Machinery Stock News

NYSE:BWA
NYSE:BWAAuto Components

Why Is BorgWarner (BWA) Expanding Its Edge In China And EV Systems?

BorgWarner (NYSE:BWA) announced multiple new contracts for variable cam timing systems in Europe and China, including a conquest award from a China based automaker. The company reported that these variable cam timing wins expand its position with existing customers and replace a competitor on a China program. BorgWarner also secured new awards for high voltage inverters and integrated drive modules for hybrid and electric vehicle platforms. The company described these contracts as material...
NasdaqGS:ORIC
NasdaqGS:ORICBiotechs

ORIC Pharmaceuticals (ORIC) Q2 Losses Put Valuation In Focus As Shares Rally

Why ORIC Pharmaceuticals Stock Is Back in Focus After Q2 Earnings ORIC Pharmaceuticals (ORIC) has drawn fresh attention after reporting second quarter and first half 2026 results, with a wider net loss but an improved basic loss per share from continuing operations. See our latest analysis for ORIC Pharmaceuticals. The earnings update and recent shelf registration have come alongside strong share price momentum. ORIC Pharmaceuticals has posted a 7 day share price return of 21.95% and a 90 day...
NYSE:WU
NYSE:WUDiversified Financial

Can Western Union (WU) Stay Cheap As Profit Pressures Persist?

Western Union stock has delivered a sharp 52.8% decline over the past 5 years, yet its current valuation checks still suggest the shares lean cheap relative to fundamentals. This makes the recent price level a key focus for investors trying to judge whether that pessimism has already been fully reflected. The 52.8% share price decline over 5 years points to a market that has marked Western Union down heavily and raises the question of whether expectations have been reset too...
NasdaqGS:TDUP
NasdaqGS:TDUPSpecialty Retail

Is ThredUp’s (TDUP) Revenue Guidance Enough To Reframe Its Loss-Making Resale Platform Narrative?

In August 2026, ThredUp Inc. reported second-quarter 2026 results showing sales of US$90.77 million versus US$77.66 million a year earlier, alongside a wider net loss of US$5.94 million and basic loss per share of US$0.05. The company also issued new revenue guidance for the third and fourth quarters and full year 2026, outlining expected mid‑single‑digit to low‑double‑digit year-over-year growth, which gives investors clearer visibility into its near-term scale ambitions despite ongoing...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Gold Royalty (GROY) Is Up 16.5% After Record H1 2026 Earnings And Reaffirmed Output Guidance

Gold Royalty Corp. recently reported its second-quarter and first-half 2026 results, with gold equivalent ounce production rising to 1,757 for the quarter and 3,677 for the half-year, alongside sales of US$6.73 million and net income of US$1.78 million in the quarter and US$3.55 million for the first six months. The company also reaffirmed its 2026 production guidance of 7,500 to 9,300 gold equivalent ounces, based on assumed gold and copper prices, underlining how its expanding royalty...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Stock May Be 27% Undervalued As AI Ultrasound Clears FDA

RadNet stock has delivered a strong 136.9% return over the past 5 years, yet today investors face mixed valuation signals as an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach screens the shares as undervalued while market multiples point to a richer price. Over 5 years RadNet has returned 136.9%, which puts extra focus on whether the current share price still leaves room for an attractive risk adjusted payoff. The recent FDA clearance for DeepHealth Breast Ultrasound...
NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Stock Rebounds As Margin Relief Meets Cash Burn Doubts

RXO stock jumped about 7% to US$21.70 after the Q2 print, a sharp move for a freight brokerage that has frustrated investors over the past month with a roughly 19% slide. The reaction hinges on one thing: the margin story finally showed some relief, even as the company remained loss making. Adjusted earnings before interest, tax, depreciation and amortization came in at US$40 million and net income loss narrowed to US$9 million on US$1.8b of revenue. For a capital tight, cash hungry model,...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Q2 Earnings And Buybacks As Fair Value Debate Returns

Why RB Global Is Back On Investors' Radar After Q2 2026 RB Global (RBA) reported Q2 2026 results and a fresh update on its capital return plans, combining higher revenue and net income with a completed share buyback and a declared dividend. This mix of earnings information and cash returns to shareholders is drawing renewed attention to RB Global stock in early August 2026, especially as investors compare its profile with other business services companies. See our latest analysis for RB...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Stock Rallies On Margin Gains And Buyback Bet

Sprout Social stock has ripped higher, jumping 26% to US$10.34 after its Q2 release, as traders rushed to reprice a business that came into the print already recovering over the past three months. The headline is simple: profit quality is catching up to the growth story. Revenue reached US$123.8m while non GAAP operating margin widened to 12.9% and non GAAP free cash flow came in at US$8.3m. The bigger story now sits on a longer clock, as management has raised full year profit guidance and is...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Says Its In House AI Tools Are Already Delivering Results

DoorDash (NasdaqGS:DASH) reported early results from its internal AI tools for merchants and order processing, highlighting tangible operational effects. CEO Tony Xu said agentic order volume from third-party AI partners is still limited compared with DoorDash’s own AI-driven systems. The company cited merchant catalog automation and AI order agents as key areas where its in-house tools are already influencing how its marketplace runs. The update gives investors a fresh view on how applied...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Is Neogen (NEOG) Still Undervalued After Flat Earnings And New Guidance?

Neogen (NEOG) recently reported fourth quarter and full year results, with revenue broadly unchanged year over year and a sharply smaller net loss, and paired this with new revenue guidance for fiscal 2027. See our latest analysis for Neogen. Neogen’s latest earnings update and new fiscal 2027 revenue guidance have come alongside strong share price momentum, with a 30 day share price return of 23.87% and a year to date share price return of 63.86%. Over a longer horizon, the 1 year total...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Stock Looks Undervalued As Its 111% Run Raises Questions

Urban Outfitters stock has delivered a strong 111.3% return over the past three years, yet the current share price around US$76.92 still screens attractively against an intrinsic value estimate from a Discounted Cash Flow (DCF) model that points to roughly 21.6% undervaluation. At the same time, traditional earnings multiples suggest the stock is trading at about the right level, so investors are weighing a discounted intrinsic value signal against a market that already prices in solid...
NasdaqGS:HCAT
NasdaqGS:HCATHealthcare Services

Health Catalyst (HCAT) Stock Price Sinks On Margin Reset Fears

Health Catalyst dropped about 25% to US$1.73 after its latest report, even though the headline numbers were not a collapse story. Q2 revenue landed at US$70.5 million and adjusted EBITDA came in at US$9.9 million, with adjusted EPS at US$0.04. The real jolt came from what happens next. The sale of the higher margin Vitalware unit, the shift to the Ignite platform and fresh guidance all reshape the earnings path from here. Investors may appreciate the recurring software revenue at Health...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Why Zevra Therapeutics (ZVRA) Is Up 21.6% After Strong MIPLYFFA Uptake And New Real-World Data

In early August 2026, Zevra Therapeutics reported Q2 2026 results showing higher sales of US$39.66 million alongside lower net income of US$8.75 million compared with the prior year, while also highlighting strong US uptake of its Niemann-Pick disease type C therapy MIPLYFFA (arimoclomol). A separate publication of four-year, real-world data on arimoclomol in a broad Niemann-Pick disease type C population, including adults, adds clinically rich evidence that extends beyond prior pivotal...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP) Taps New Product Leader To Sharpen Illumia's AI Focus

Roper Technologies (NasdaqGS:ROP) subsidiary Illumia has appointed Eric Schuster as Chief Product Officer. Schuster brings extensive AI and enterprise software leadership experience from senior roles at ADP and Ceridian/Dayforce. The appointment is expected to shape Illumia's product roadmap, with a focus on client-centric solutions and practical AI use cases. For investors watching how AI and vertical SaaS shape long term software portfolios, it can be useful to look at a wider group of...
NYSE:LVS
NYSE:LVSHospitality

Las Vegas Sands (LVS) Stock Looks Fairly Valued Following Its 30% Slide

Las Vegas Sands stock has fallen 29.8% year to date, yet current checks suggest the shares may now sit close to their intrinsic value rather than being clearly cheap or expensive. Year to date the share price is down 29.8%, which puts recent sentiment under pressure and makes today's valuation levels especially important for new money going into Las Vegas Sands. Recent commentary around Macau and Singapore softness can weigh on growth expectations, while continued strength in domestic gaming...
NYSE:HR
NYSE:HRHealth Care REITs

Will New US$775 Million Shelf, Ongoing Losses And Dividends Change Healthcare Realty Trust's (HR) Narrative?

In late July 2026, Healthcare Realty Trust filed shelf registrations covering up to US$775.08 million of securities, reported a second-quarter 2026 net loss of US$43.51 million on US$281.85 million in revenue, affirmed a US$0.24 per-share dividend, and updated full-year 2026 guidance to a loss per share between US$0.15 and US$0.11. Alongside these filings and results, the company kept its dividend intact while having completed US$99.88 million of prior share repurchases, underscoring a...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku (ROKU) Stock Looks Repriced After Profitability Breakthrough

Roku stock inched up about 2% after earnings, which might look like a routine move for a company often framed as either a streaming winner in waiting or an overhyped advertising platform. The headline is less subtle. Roku just posted roughly US$1.11 in basic earnings per share on quarterly revenue of about US$1.35b, building on a trailing 12 month profit profile that now shows more than US$355m in earnings from continuing operations. The market reaction so far feels restrained compared with...